Caricamento...
Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
BACKGROUND: Agranulocytosis is regarded as a rare side effect of methimazole (MMI) therapy that occurs in a dose dependent manner and that usually develops within the first 3–6 months of treatment. Although delayed development beyond this timeline has been documented in adults, very few children hav...
Salvato in:
| Pubblicato in: | Int J Pediatr Endocrinol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013617/ https://ncbi.nlm.nih.gov/pubmed/27605984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13633-016-0034-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|